Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A single-dose study of TMS-007 in patients with ischemic stroke (phase IIa)
jRCT2080223786Phase 2Completed
- Sponsor
- TMS Co., Ltd.
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of JX10 in ischemic stroke and brain infarction (4 arms), sponsored by TMS Co., Ltd. Started Jan 2018; status: completed.
02
Drugs
JX10
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on jRCT2080223786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223786.